Literature DB >> 6979043

Reciprocal modulation of agonist and antagonist binding to muscarinic cholinergic receptor by guanine nucleotide.

E Burgisser, A De Lean, R J Lefkowitz.   

Abstract

The ability of guanine nucleotide to decrease the binding affinity of agonists but not antagonists has been documented in a number of hormone and neurotransmitter receptor systems. By contrast, recent reports indicate that both agonist and antagonist binding to the muscarinic cholinergic receptors appear to be regulated in a reciprocal fashion by guanine nucleotide. We document two forms of the muscarinic cholinergic receptor in frog heart, which are present in approximately equal proportions and which display high-agonist/low antagonist and low-agonist/high-antagonist affinities, respectively. Guanine nucleotide appears to convert the former type of site into the latter type. These observations can be interpreted in terms of a model for two interconvertible forms of the muscarinic cholinergic receptor reciprocally favored by agonists and antagonists. This model has implications both for the understanding of neurotransmitter-receptor interactions generally and for the nature of the biological effects of receptor antagonists.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6979043      PMCID: PMC346054          DOI: 10.1073/pnas.79.6.1732

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  22 in total

1.  An agonist-specific effect of guanine nucleotides on binding to the beta adrenergic receptor.

Authors:  M E Maguire; P M Van Arsdale; A G Gilman
Journal:  Mol Pharmacol       Date:  1976-03       Impact factor: 4.436

Review 2.  Pharmacological characterization of receptors: its relation to radioligand-binding studies.

Authors:  R F Furchgott
Journal:  Fed Proc       Date:  1978-02

3.  Regulation of beta-adrenergic receptors by guanyl-5'-yl imidodiphosphate and other purine nucleotides.

Authors:  R J Lefkowitz; D Mullikin; M G Caron
Journal:  J Biol Chem       Date:  1976-08-10       Impact factor: 5.157

4.  The regulation of muscarinic cholinergic receptors by guanine nucleotides in cardiac tissue.

Authors:  L B Rosenberger; W R Roeske; H I Yamamura
Journal:  Eur J Pharmacol       Date:  1979-06       Impact factor: 4.432

5.  Guanine nucleotides modulate muscarinic receptor binding in the heart.

Authors:  C P Berrie; N J Birdsall; A S Burgen; E C Hulme
Journal:  Biochem Biophys Res Commun       Date:  1979-04-27       Impact factor: 3.575

6.  Muscarinic acetylcholine receptors in developing chick heart.

Authors:  J B Galper; W Klein; W A Catterall
Journal:  J Biol Chem       Date:  1977-12-10       Impact factor: 5.157

7.  Effect of guanine nucleotides on striatal dopamine receptors.

Authors:  N R Zahniser; P B Molinoff
Journal:  Nature       Date:  1978-10-05       Impact factor: 49.962

8.  Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves.

Authors:  A DeLean; P J Munson; D Rodbard
Journal:  Am J Physiol       Date:  1978-08

9.  The binding of agonists to brain muscarinic receptors.

Authors:  N J Birdsall; A S Burgen; E C Hulme
Journal:  Mol Pharmacol       Date:  1978-09       Impact factor: 4.436

10.  Identification of adenylate cyclase-coupled beta-adrenergic receptors in frog erythrocytes with (minus)-[3-H] alprenolol.

Authors:  C Mukherjee; M G Caron; M Coverstone; R J Lefkowitz
Journal:  J Biol Chem       Date:  1975-07-10       Impact factor: 5.157

View more
  30 in total

Review 1.  Inverse agonism at G protein-coupled receptors: (patho)physiological relevance and implications for drug discovery.

Authors:  R A de Ligt; A P Kourounakis; A P IJzerman
Journal:  Br J Pharmacol       Date:  2000-05       Impact factor: 8.739

2.  Modulation of the structure-binding relationships of antagonists for muscarinic acetylcholine receptor subtypes.

Authors:  E K Pedder; P Eveleigh; D Poyner; E C Hulme; N J Birdsall
Journal:  Br J Pharmacol       Date:  1991-06       Impact factor: 8.739

3.  Binding of the novel radioligand [(3)H]UFP-101 to recombinant human and native rat nociceptin/orphanin FQ receptors.

Authors:  Massimo Ibba; Masato Kitayama; John McDonald; Girolamo Calo; Remo Guerrini; Judit Farkas; Geza Toth; David G Lambert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-09-21       Impact factor: 3.000

Review 4.  The role of G proteins in transmembrane signalling.

Authors:  C W Taylor
Journal:  Biochem J       Date:  1990-11-15       Impact factor: 3.857

5.  Antagonists with negative intrinsic activity at delta opioid receptors coupled to GTP-binding proteins.

Authors:  T Costa; A Herz
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

Review 6.  G protein-coupled receptor oligomerization revisited: functional and pharmacological perspectives.

Authors:  Sergi Ferré; Vicent Casadó; Lakshmi A Devi; Marta Filizola; Ralf Jockers; Martin J Lohse; Graeme Milligan; Jean-Philippe Pin; Xavier Guitart
Journal:  Pharmacol Rev       Date:  2014-02-10       Impact factor: 25.468

7.  Impaired cardiac muscarinic receptor function in dogs with heart failure.

Authors:  D E Vatner; D L Lee; K R Schwarz; J P Longabaugh; A M Fujii; S F Vatner; C J Homcy
Journal:  J Clin Invest       Date:  1988-06       Impact factor: 14.808

8.  Propylbenzilylcholine mustard is selective for rat heart muscarinic receptors having a low affinity for agonists.

Authors:  J Christophe; P De Neef; P Robberecht; M Waelbroeck
Journal:  Br J Pharmacol       Date:  1986-05       Impact factor: 8.739

9.  Interactions of purified bovine brain A1-adenosine receptors with G-proteins. Reciprocal modulation of agonist and antagonist binding.

Authors:  M Freissmuth; E Selzer; W Schütz
Journal:  Biochem J       Date:  1991-05-01       Impact factor: 3.857

10.  Expression of two human beta-adrenergic receptors in Escherichia coli: functional interaction with two forms of the stimulatory G protein.

Authors:  M Freissmuth; E Selzer; S Marullo; W Schütz; A D Strosberg
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.